CRISPR Therapeutics AG

1CG.MU·Munich
Compare
46.02+1.36 (+3.05%)today
As of Nov 5, 8:03 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close44.66
Open46.02
Day range—
52-week range39.2053.96
Off day high0.00%
Off 52-week high−14.71%
Volume0.00
Avg. volume (3M)318
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
1CG.MU SCTX NTLA EDIT SANA PRQR
Market cap — 317.67M 1.72B 417.74M 766.36M 198.98M
P/E (TTM) — — — — — —
Forward P/E — -4.6 -4.8 -3.6 -4.6 -3.0
Price/book — -0.3 2.4 4.0 5.0 2.2
Dividend yield — — — — — —
1-year change −10.32% −11.54% −12.60% +1.12% −36.79% −42.44%
Today +3.05% +3.58% +3.79% +4.62% +4.92% +2.92%

The closest companies by business. Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to CRISPR Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Scribe Therapeutics Inc.SCTX · Biotechnology 317.67M 16.78 +3.58%
Intellia Therapeutics, Inc.NTLA · Biotechnology 1.72B 12.31 +3.79%
Editas Medicine, Inc.EDIT · Biotechnology 417.74M 2.7200 +4.62%
Sana Biotechnology, Inc.SANA · Biotechnology 766.36M 2.5600 +4.92%
ProQR Therapeutics N.V.PRQR · Biotechnology 198.98M 1.4100 +2.92%
Genprex, Inc.GNPX · Biotechnology 1.75M 2.1400 −7.36%
Precision BioSciences, Inc.DTIL · Biotechnology 226.84M 8.12 +16.50%
Caribou Biosciences, Inc.CRBU · Biotechnology 47.64M 0.4444 −3.27%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All 1CG.MU news ›
MarketScreener··2 outletsPositive

Crispr Therapeutics Announces Appointment of Sivakesava Sakhamuri as Chief Technical Officer, Effective November 2, 2026

CRISPR Therapeutics announced the appointment of Sivakesava Sakhamuri, Ph.D., as Chief Technical Officer, effective November 2, 2026. Dr. Sakhamuri brings about 30 years of technical operations and... CRISPR Therapeutics announced the…

CRSPVRTX
More from 1 other outlet
MarketScreener·Positive

CRISPR Therapeutics AG Announces CFO Changes

CRISPR Therapeutics AG announced the promotion of Andrew J. Silver, currently the Company's SVP, Finance, to be the Company's Chief Financial Officer effective October 19, 2026. Since January 2025,... CRISPR Therapeutics AG announced the…

CRSPVRTX

From the 4Search news index, newest first.

In the news

62mentions in 30 days
62with it in the headline
Positivesentiment

Mentioned with

Therapeutics AG58Crispr Therapeutics AG57Vertex Pharmaceuticals57U.S. Food and Drug Administration53Crispr34Finance29Ernst & Young Llp22Morgan Stanley Smith Barney Llc19

People in the coverage

Casgevy53Crispr53Cathie Wood45Samarth Kulkarni34James R. Kasinger32James Halley31

Themes

Crsp59Healthcare47Biotechnology42SEC Filings40Crispr Therapeutics AG35Usmf-Health-Care25Finanzen23Form 421

Most coverage from

  1. markets.businessinsider.com9
  2. marketscreener.com7
  3. stocktitan.net6
  4. fool.com5
  5. marketbeat.com5

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 62 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance